Table 1 Baseline characteristics of deaths from MNFGO in Shanghai PNA, 1995–2018
Site | Deaths (N, %) | Age in years (Mean ± SD) | Age in years (Median) | CMR (/105) | ASMRW (/105) | YLL (years) | YLL rate (/105) |
|---|---|---|---|---|---|---|---|
Vulva cancer (C51) | 71 (2.47) | 77.50 ± 11.32 | 79.12 | 0.23 | 0.09 | 661.58 | 2.13 |
Vagina cancer (C52) | 40 (1.39) | 69.15 ± 12.58 | 70.43 | 0.13 | 0.06 | 518.42 | 1.67 |
Cervix uteri cancer (C53) | 677 (23.60) | 63.51 ± 16.86 | 62.59 | 2.18 | 1.14 | 10,272.51 | 33.04 |
Corpus uteri cancer (C54) | 293 (10.21) | 67.72 ± 11.88 | 67.65 | 0.94 | 0.47 | 4007.61 | 12.89 |
Uterus unspecified cancer (C55) | 471 (16.42) | 69.41 ± 14.14 | 70.38 | 1.15 | 0.72 | 6075.53 | 19.54 |
Ovary cancer (C56) | 1260 (43.92) | 62.86 ± 13.54 | 62.08 | 4.05 | 2.23 | 19,763.83 | 63.56 |
Other female genital organs cancer (C57) | 56 (1.95) | 65.56 ± 10.03 | 66.01 | 0.18 | 0.10 | 826.37 | 2.66 |
Placenta cancer (C58) | 1 (0.03) | 28.17 | 28.17 | 0.00 | 0.00 | 26.98 | 0.09 |
Total | 2869 (100.00) | 65.08 ± 14.59 | 64.92 | 9.23 | 4.8 | 42,152.82 | 135.56 |